Imago BioSciences Geçmiş Kazanç Performansı
Geçmiş kriter kontrolleri 0/6
Imago BioSciences's earnings have been declining at an average annual rate of -57.6%, while the Biotechs industry saw earnings growing at 17.4% annually.
Anahtar bilgiler
-57.6%
Kazanç büyüme oranı
65.7%
EPS büyüme oranı
| Biotechs Sektör Büyümesi | 17.0% |
| Gelir büyüme oranı | n/a |
| Özkaynak getirisi | -35.7% |
| Net Marj | n/a |
| Son Kazanç Güncellemesi | 30 Sep 2022 |
Yakın geçmiş performans güncellemeleri
Güncelleme yok
Recent updates
Imago BioSciences (NASDAQ:IMGO) Is In A Good Position To Deliver On Growth Plans
Nov 08
Imago BioSciences GAAP EPS of -$0.41 beats by $0.09
Aug 12Here's Why We're Not Too Worried About Imago BioSciences' (NASDAQ:IMGO) Cash Burn Situation
Jul 26Companies Like Imago BioSciences (NASDAQ:IMGO) Are In A Position To Invest In Growth
Apr 12We're Not Very Worried About Imago BioSciences' (NASDAQ:IMGO) Cash Burn Rate
Dec 08Gelir ve Gider Dağılımı
Imago BioSciences nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.
Kazanç ve Gelir Geçmişi
| Tarih | Gelir | Kazançlar | G+A Giderleri | Ar-Ge Giderleri |
|---|---|---|---|---|
| 30 Sep 22 | 0 | -62 | 16 | 47 |
| 30 Jun 22 | 0 | -57 | 15 | 42 |
| 31 Mar 22 | 0 | -52 | 12 | 40 |
| 31 Dec 21 | 0 | -42 | 10 | 32 |
| 30 Sep 21 | 0 | -33 | 9 | 25 |
| 30 Jun 21 | 0 | -26 | 6 | 20 |
| 31 Mar 21 | 0 | -21 | 5 | 16 |
| 31 Dec 20 | 0 | -18 | 3 | 15 |
Kaliteli Kazançlar: IMGO is currently unprofitable.
Büyüyen Kar Marjı: IMGO is currently unprofitable.
Serbest Nakit Akışı ve Kazanç Analizi
Geçmiş Kazanç Büyüme Analizi
Kazanç Eğilimi: Insufficient data to determine if IMGO's year-on-year earnings growth rate was positive over the past 5 years.
Büyüme Hızlandırma: Unable to compare IMGO's earnings growth over the past year to its 5-year average as it is currently unprofitable
Kazançlar vs. Sektör: IMGO is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (-42.7%).
Özkaynak Getirisi
Yüksek ROE: IMGO has a negative Return on Equity (-35.71%), as it is currently unprofitable.